Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Obesity Management Market, by Region, 2020-2028 (USD Billion)
1.2.2. Obesity Management Market, by Drug, 2020-2028 (USD Billion)
1.2.3. Obesity Management Market, by Surgery, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Obesity Management Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Obesity Management Market Dynamics
3.1. Obesity Management Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increase in the global obese population
3.1.1.2. Strategic collaborations among the players
3.1.2. Market Challenges
3.1.2.1. High cost of surgeries
3.1.2.2. Safety concerns about obesity management drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing obesity in children and adolescents
3.1.3.2. Rise in awareness regarding health issues
Chapter 4. Global Obesity Management Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Obesity Management Market, by Drug
6.1. Market Snapshot
6.2. Global Obesity Management Market by Drug, Performance - Potential Analysis
6.3. Global Obesity Management Market Estimates & Forecasts by Drug, 2019-2028 (USD Billion)
6.4. Obesity Management Market, Sub Segment Analysis
6.4.1. Bupropion and Naltrexone
6.4.2. Orlistat
6.4.3. Lorcaserin
6.4.4. Phentermine and Topiramate
6.4.5. Liraglutide
Chapter 7. Global Obesity Management Market, by Surgery
7.1. Market Snapshot
7.2. Global Obesity Management Market by Surgery, Performance - Potential Analysis
7.3. Global Obesity Management Market Estimates & Forecasts by Surgery, 2019-2028 (USD Billion)
7.4. Obesity Management Market, Sub Segment Analysis
7.4.1. Gastric Bypass Surgery
7.4.2. Adjustable Gastric Banding Surgery
7.4.3. Gastric Sleeve Surgery
7.4.4. Duodenal Switch Surgery
7.4.5. Other
Chapter 8. Global Obesity Management Market, Regional Analysis
8.1. Obesity Management Market, Regional Market Snapshot
8.2. North America Obesity Management Market
8.2.1. U.S. Obesity Management Market
8.2.1.1. Drug breakdown estimates & forecasts, 2019-2028
8.2.1.2. Surgery breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Obesity Management Market
8.3. Europe Obesity Management Market Snapshot
8.3.1. U.K. Obesity Management Market
8.3.2. Germany Obesity Management Market
8.3.3. France Obesity Management Market
8.3.4. Spain Obesity Management Market
8.3.5. Italy Obesity Management Market
8.3.6. Rest of Europe Obesity Management Market
8.4. Asia-Pacific Obesity Management Market Snapshot
8.4.1. China Obesity Management Market
8.4.2. India Obesity Management Market
8.4.3. Japan Obesity Management Market
8.4.4. Australia Obesity Management Market
8.4.5. South Korea Obesity Management Market
8.4.6. Rest of Asia Pacific Obesity Management Market
8.5. Latin America Obesity Management Market Snapshot
8.5.1. Brazil Obesity Management Market
8.5.2. Mexico Obesity Management Market
8.6. Rest of The World Obesity Management Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Weight watchers international (us)
9.2.1.1. Key information
9.2.1.2. Overview
9.2.1.3. Financial (subject to data availability)
9.2.1.4. Product summary
9.2.1.5. Recent developments
9.2.2. Jenny craig (us)
9.2.3. Atkins nutritionals, inc. (us)
9.2.4. Herbalife ltd. (us)
9.2.5. Nutrisystem ltd. (us)
9.2.6. Kellogg company (us)
9.2.7. Ethicon, inc. (us)
9.2.8. Covidien, plc. (us)
9.2.9. Apollo endosurgery (us)
9.2.10. Olympus corporation (olympus) (japan)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption